Jan 23, 2015 at 10:19 | Source: Moneycontrol.com
Wockhardt Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 4, 2015 inter alia, to consider and approve the unaudited financial results (consolidated and standalone) of the Company for the third quarter and nine months ended 31st December 2014 (Q3).
Jan 20, 2015 at 13:28 | Source: CNBC-TV18
The market currently is discovering new stories to take it up but banking will continue to be the driving force. "The stock market theory is rested on the banking sector and no other sector is likely to take it up, says Ajay Srivastava.
Jan 20, 2015 at 11:44 | Source: Moneycontrol.com
Pharma stocks like Strides Arcolab, Lupin, Glenmark Pharma,Wockhardt, Lyka Labs will get astro support, says Satish Gupta of astrostocktips.
Jan 19, 2015 at 14:48 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, housing finance sector will continue getting strong astrological support and advises buying Dewan Housing Finance Corporation, GIC Housing, GRUH Finance, Indiabulls Housing, Ganesh Housing and LIC Housing on dips.
Jan 19, 2015 at 13:32 | Source: CNBC-TV18
Kunal Saraogi of Equityrush is of the view that Wockhardt may test Rs 1100.
Jan 19, 2015 at 13:10 | Source: CNBC-TV18
Watch the interview of Kunal Saraogi of Equityrush with Reema Tendulkar & Latha Venkatsh on CNBC-TV18, in which he shared his readings and outlook on market and specific stocks.
Jan 13, 2015 at 10:45 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips, paints stocks like Asian Paints, Shalimar Paints, Akzo Nobel and Jenson Nicholson will get astro support.
Jan 12, 2015 at 10:21 | Source: Moneycontrol.com
Housing finance sector will continue getting strong astrological support. Buy Canfin Home, GIC Housing, Indiabulls Housing, DHFL, Ganesh Housing and LIC Housing on dips, says Satish Gupta of Astrostocktips.
Jan 08, 2015 at 21:51 | Source: CNBC-TV18
Indian drug makers are finding themselves under the gun as run-ins with global drug regulators are on the rise. This is being seen as a golden opportunity by Merck Millipore, the life sciences division of German drug maker Merck, which also works on setting up high quality drug manufacturing processes, reports Archana Shukla.
Jan 08, 2015 at 14:22 | Source: CNBC-TV18
Kunal Saraogi of Equityrush recommends buying Wockhardt with a target of Rs 1080.